Solace Therapeutics
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
135 Newbury St Ste 1, Framingham, Massac...Phone Number
(508) 283-1200Website
www.solacecounseling.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Solace Therapeutics
Solace Therapeutics is an emerging women's health company focused on a new office-based treatment for symptoms of female SUI. SUI is the most prevalent form of incontinence among women and affects an estimated 15 million adult women in the U.S. These women choose to manage their SUI by utilizing absorbent products such as protective pads versus seeking medical help. Solace is dedicated to improving the quality of life for women whose daily life is disrupted by their incontinence.Explore more
Solace Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Solace Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Solace Therapeutics launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Solace Therapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Solace Therapeutics
Solace Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Click to see if Solace Therapeutics had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Solace Therapeutics has new funding data
Check if Solace Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Solace Therapeutics recently announced quarterly report
Recommended Actions
Find VP level buyers at Solace Therapeutics
Find 3 more new buyers
Compare Similar Companies to Solace Therapeutics
Compare insights from companies similar to Solace Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Solace Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Solace Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Solace Therapeutics.
Solace Therapeutics financials insights
Gather financial insights about Solace Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2012
Private Equity
$7M
2016
Private Equity
$13M
2020
Debt
$150K
2021
Debt
$233K
Solace Therapeutics Tech Stack
A closer look at the technologies used by Solace Therapeutics
Solace Therapeutics News & Media
Solace Therapeutics Announces that Dr. Cindy Basinski and Team at CMB Research Enrolls First Patient in US Pivotal Clinical Trial, using New Office-Based Treatment for Female Stress Urinary Incontinence (SUI)
NEWBURGH, Ind.--(BUSINESS WIRE)--Dr. Cindy Basinski and Team at CMB Research, has enrolled their first patient in the VESAIR Clinical Trial. The VESAIR Clinical Trial is being conducted in several distinguished clinics throughout the US to test the safety and efficacy of the Vesair Bladder Control Balloon procedure. “I am delighted to be participating in the VESAIR Clinical Study. SUI is not life-threatening, but if left untreated, it can greatly diminish a woman’s Quality of Life.Solace Therapeutics Announces that Mercy Health Urogynecology Enrolls First Patient in US Pivotal Clinical Trial, Using New Office-Based Treatment for Female Stress Urinary Incontinence (SUI)
ADA, Mich.--(BUSINESS WIRE)--Mercy Health Urogynecology, has enrolled their first patient in the VESAIR Clinical Trial. The VESAIR Clinical Trial is being conducted in several distinguished clinics throughout the US to test the safety and efficacy of the Vesair Bladder Control Balloon procedure. “I am delighted to be participating in the VESAIR Clinical Study. SUI is not life-threatening, but if left untreated, it can greatly diminish a woman’s Quality of Life. Having a non-surgical option woulSolace Therapeutics Announces That MetroHealth Enrolls First Patient in US Pivotal Clinical Trial, Using New Office-Based Treatment for Female Stress Urinary Incontinence(SUI)
CLEVELAND--(BUSINESS WIRE)--MetroHealth, has enrolled their first patient in the VESAIR Clinical Trial. The VESAIR Clinical Trial is being conducted in several distinguished clinics throughout the US to test the safety and efficacy of the Vesair Bladder Control Balloon procedure. “I am delighted to be participating in the VESAIR Clinical Study. SUI is not life-threatening, but if left untreated, it can greatly diminish a woman’s Quality of Life. Having a non-surgical option would be a greatSolace Therapeutics Announces that ProHEALTHcare Garden City Urology Enrolls First Patient in US Pivotal Clinical Trial, Using New Office-Based Treatment for Female Stress Urinary Incontinence (SUI)
GARDEN CITY, N.Y.--(BUSINESS WIRE)--ProHEALTHcare Garden City Urology, has enrolled their first patient in the VESAIR Clinical Trial. The VESAIR Clinical Trial is being conducted in several distinguished clinics throughout the US to test the safety and efficacy of the Vesair Bladder Control Balloon procedure. “I am delighted to be participating in the VESAIR Clinical Study. SUI is not life-threatening, but if left untreated, it can greatly diminish a woman’s Quality of Life. Having a non-surgic
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Solace Therapeutics
Sign Up For FreeTo access detailed company insights
Solace Therapeutics is an emerging women's health company focused on a new office-based treatment for symptoms of female SUI. SUI is the most prevalent form of incontinence among women and affects an estimated 15 million adult women in the U.S. These women choose to manage their SUI by utilizing absorbent products such as protective pads versus see... Read More
